slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 73,891-73,920
Pages 3,679
Rows per page 30
Component
73,891-73,920 of 110,355
08
Includes a table of revenue drivers and a stacked bar chart showing revenue composition.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations 1 hit
09
Includes footnotes regarding non-GAAP measures and EPS variance drivers.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations 1 hit
10
Includes specific impact callouts for the Uni-Select acquisition.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a waterfall chart to explain the variance in EBITDA margin between Q3 2022 and Q3 2023.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
Includes footnotes detailing definitions of debt, capacity, and interest rates.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations 1 hit
21
Includes detailed commentary on drivers for each segment's performance.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
22
Includes non-GAAP reconciliations and specific variance drivers for EPS.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
23
Includes a waterfall chart (bridge) explaining the change in EBITDA margin.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
27
Includes a line chart for metals prices and three tables for EBITDA impact and FX rates.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Visualization1 hit
35
Includes footnotes regarding Uni-Select acquisition and Ukraine/Russia conflict impacts.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
38
Standard financial reconciliation slide for non-GAAP measures.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
39
Includes a footnote regarding the exclusion of gains from business disposals in FCF conversion.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
12
Part of a Q3 2023 revenue presentation.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
14
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
21
Part of a Q3 2023 revenue presentation.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
12
The chart shows tumor volume over time, highlighting the efficacy of the THIO + Atezo combination compared to controls.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
13
The slide outlines a clinical trial process flow including randomization and expansion phases.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
15
The slide highlights that THIO has a better safety profile than standard chemotherapy, which typically has 70-80% incidence of Grade 3-5 side effects.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
16
DCR stands for Disease Control Rate. The table compares historical clinical trial data (KEYNOTE 024, REVEL, RWD) against the company's own THIO-101 trial data.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
18
DCR = Disease Control Rate. Data presented in three separate tables for different dose cohorts.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
19
Clinical trial data visualization showing patient-level outcomes over time.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
21
The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
23
The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
24
The slide presents two line charts showing tumor volume reduction and long-term survival/rechallenge success.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
31
The slide outlines a clinical trial process flow from initial baskets through immune activation to a pivotal phase.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
34
Includes details on options, warrants, and insider ownership percentage.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
37
The slide uses a logo-grid and metric-grid to establish valuation context.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Market Size1 hit
06
Includes a process diagram for the test workflow and product imagery.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Product1 hit
08
The slide presents clinical validation data for the ColoAlert diagnostic test.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
12
AA = Advanced Adenoma; CRC = Colorectal Cancer. Data sourced from JNCI 2022.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit